Be Familiar With the Latest Oral Multiple Sclerosis Meds
You’ll hear about a flurry of new ORAL meds to treat multiple sclerosis (MS)...such as Mayzent, Vumerity, and Zeposia.
Expect patients with relapsing-remitting MS to usually start treatment right away...to reduce flares and slow progression.
We’re used to seeing the injectables (Avonex, Copaxone, etc) first-line. Or patients with more severe disease may jump right to a monoclonal antibody IV infusion (Lemtrada, Tysabri, etc).